This study is testing an experimental drug called MRG003 for people with advanced nasopharyngeal cancer that has returned or spread after previous treatments. It aims to see if MRG003 can shrink tumors and control the disease better than current standard chemotherapy options. The…
Phase: PHASE2 • Sponsor: Shanghai Miracogen Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC